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Among covid-19 and Brexit articles dominating the headlines in the final months of 
2020, there was one other issue that attracted attention from the media. Multiple reports 
of high-profile former soccer and rugby players with neurodegenerative disease 
diagnoses generated concern over possible adverse brain health consequences of 
contact sport participation, with litigation threatened against sports organisations over 
perceived failures in duty of care to former players. But are these concerns justified? Is 
there evidence supporting a link between sport and dementia? If so, what might be 
done to mitigate risk? 
 
Traumatic brain injury (TBI) is acknowledged as one major risk factor for 
neurodegenerative disease, contributing to around 3-15% of dementia in the 
community.1,2 In context of sport, the link between TBI and neurodegenerative disease 
was first proposed almost a century ago in descriptions of the punch drunk syndrome of 
boxers,3 with the associated pathology defined in the following decades as dementia 
puglisitica.4 Throughout the twentieth century this issue remained largely confined to 
boxers. In the last twenty years, however, there has been growing recognition of the 
pathology of dementia pugilistica, now termed chronic traumatic encephalopathy (CTE), 
among non-boxer athletes from a range of contact sports, including soccer,5 rugby6 and 
American football,7 and others with non-sports exposure to TBI.8 As such, the pathology 
of CTE is now widely acknowledged as intimately associated with prior history of TBI or 
exposure to repetitive head impacts.8,9 Elsewhere, neurodegenerative mortality among 
former professional soccer players and American footballers is considerably higher than 
expected.10,11 Thus, neurodegenerative disease risk is high in former contact sports 
athletes, with autopsy studies demonstrating the TBI-related neurodegenerative 
pathology CTE in a majority.  
 
First, do no harm 
Addressing sports associated neurodegenerative disease, therefore, requires 
understanding of the brain health consequences of TBI, which, for athletes, might be 
considered in three broad life periods:  
- Early-life: while participating in sport and exposed to injury 
- Mid-life: retired from sport and no longer exposed to injury 
- Late-life: when disease might emerge.  
To date, the only identified risk factor for neurodegenerative disease associated with 
contact sports remains TBI. Therefore, adopting a precautionary principle approach to 
managing an athlete’s early-life, every effort should be pursued to reduce head impact 
exposure and to better recognise and manage TBI in all sport.   
 
Second, act to reduce harm 
While TBI prevention is the priority for risk reduction, retired athletes have already 
accumulated TBI and head impact exposure. In this mid-life period, therefore, the goal 
is to identify evidence of potential brain health issues and act to reduce their 
consequences. This is in line with current research and management of wider, non-
sport neurodegenerative disease. Knowledge regarding the mid-life onset of 
neurodegenerative disease has been accumulating over the last decade12 through 
programmes like PREVENT Dementia13 and the European Prevention of Alzheimer’s 
Dementia programme.14 These initiatives have informed the development of national 
policy (eg Brain Health Scotland)15 and specialist Brain Health Clinics founded on three 
broad goals to: [1] provide detailed risk profiling; [2] detect early disease; and [3] provide 
personalised prevention plans.16,17 This approach provides an ideal pathway for former 
contact sport athletes to obtain independent, specialist clinical review and advice on 
measures to improve brain health that might serve to reduce the long-term 
consequences of previous exposure to TBI. 
 
Third, recognise the late consequences 
Consensus criteria for clinical diagnosis of CTE are yet to be established, however, data 
demonstrate neurodegenerative diagnoses in former athletes are broad and not 
confined to diseases that might be confused clinically with CTE.10,11 Further, autopsy 
studies demonstrate that while CTE pathology is present in most former athletes with 
dementia, it is more often a co-morbidity rather than the primary disease responsible for 
dementia.5 Thus, while efforts to better recognise CTE in vivo are welcomed, in the 
majority of former contact sports athletes the neurodegenerative disease diagnosis 
need not be CTE. Given this, clinical management in any patient should be guided by 
best practice protocols for whichever diagnosis is appropriate. The goals in this late life 
phase, therefore, are recognition that sport may be implicated in the individual’s risk 
profile to record cases for surveillance purposes and, where possible, to engage 
patients in research directed towards understanding the influence of sport on lifelong 
brain health, including autopsy studies. 
 
Prevention is the cure 
Current best evidence supports the association between elite-level contact sports 
participation and increased risk of neurodegenerative disease which, on the balance of 
probabilities, is a consequence of exposure to repetitive head impacts and TBI. In the 
coming years, whether global sports acted appropriately in past to reduce lifelong brain 
health issues associated with TBI and head impacts will be tested in the courts. In the 
meantime, the question for sport to consider in 2021 is, are current policies sufficient to 
reduce risk of TBI related neurodegenerative disease for today’s athletes?   
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